Significance of diagnostic laparoscopy and determination of free cancer cells in peritoneal lavage fluid in patients with gastric carcinoma

Nenad Perišić; Zoran Kostić; Radoje Doder; Irina Brčerević; Stanko Petrović; Damjan Slavković

doi:10.2298/VSP181219012P

Nenad Perišić Military Medical Academy, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia
Zoran Kostić Military Medical Academy, Clinic for General Surgery, Belgrade, Serbia
Radoje Doder Military Medical Academy, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia
Irina Brčerević Military Medical Academy, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia
Stanko Petrović Military Medical Academy, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia
Damjan Slavković Military Medical Academy, Clinic for General Surgery, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP181219012P

Keywords: stomach neoplasms, laparoscopy, peritoneal lavage, cells, diagnostic techniques and procedures

References

Hoskovec D, Varga J, Dytrych P, Konecna E, Matek J. Peritoneal lavage examination as a prognostic tool in cases of gastric can-cer. Arch Med Sci 2017; 13(3): 612‒6.

Global Cancer Facts & Figures, 3rd ed. American Cancer So-ciety. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-3rd-edition.pdf. [accessed 2018 April 24].

World Health Organization. Cancer. WHO. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/. February 1 2018; [accessed 2018 April 24].

The Public Health Institute of Serbia “Dr Milan Jovanovic Batut”. Statistical Yearbook 2017. Belgrade: The Public Health Institute of Serbia “Dr Milan Jovanovic Batut”; 2017. Available from: www.batut.org.rs/publikacije.

Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Stomach Cancer. Bethesda, MD: National Cancer Institute; 2004. Available at http://seer.cancer.gov/statfacts/html/stomach.html. [ac-cessed 2017 August 1].

Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11(2): 235‒56.

Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 1997; 225(3): 262‒7.

Fielding JWL, Powell J, Allum WH. Cancer of the Stomach. London: The Macmillan Press; 1989.

Tsukuma H, Mishima T, Oshima A. Prospective study of "ear-ly" gastric cancer. Int J Cancer 1983; 31(4): 421‒6.

Andrew M. Blakely, Thomas J. Miner. Surgical Considerations in the Treatment of Gastric Cancer. Gastroenterol Clin North Am 2013; 42(2): 337–57.

Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising inci-dence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265(10): 1287‒9.

Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, et al. Mechanisms and sequelae of E-cadherin silencing in heredi-tary diffuse gastric cancer. J Pathol 2008; 216(3): 295‒306.

Fidler IJ. Critical factors in the biology of human cancer me-tastasis: twenty-eighth G. H. A. Clowes Memorial Award Lec-ture. Cancer Res 1990; 50(19): 6130‒8.

Resende C, Ristimäki A, Machado JC. Genetic and epigenetic al-teration in gastric carcinogenesis. Helicobacter 2010; 15 Suppl1: 34‒9.

Calcagno DQ, Gigek CO, Chen ES, Burbano RR, Smith Mde A. DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol 2013; 19(8): 1182‒92

Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric can-cer. World J Gastroenterol 2014; 20(38): 13804‒19.

Saario I, Schröder T, Lempinen M, Kivilaakso E, Nordling S. Anal-ysis of 58 patients surviving more than ten years after opera-tive treatment of gastric cancer. Arch Surg 1987; 122(9): 1052‒4.

Gerzić Z. Carcinoma of the stomach. In: Dragović M, Gerzić Z, editors. Basics of surgery. Belgrade: Medicinska knjiga; 1999. p. 1303‒15. (Serbian)

Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000; 87(3): 353‒7.

Averbach AM, Jacquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996; 83(6): 726‒33.

Jaehne J, Meyer HJ, Maschek H, Geerlings H, Math D, Bruns E, et al. Lymphadenectomy in gastric carcinoma: a prospective and prognostic study. Arch Surg 1992; 127(3): 290‒4.

Tourani SS, Cabalag C, Link E, Chan ST, Duong CP. Laparos-copy and peritoneal cytology: important prognostic tools to guide treatment selection in gastric adenocarcinoma. ANZ J Surg 2015; 85(1‒2): 69‒73.

Kiyasu Y, Kaneshima S, Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 1981; 41(3): 1236‒9.

Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, et al. Prognostic significance of serosal invasion and free in-traperitoneal cancer cells in gastric cancer. Br J Surg 1990; 77(4): 436‒9.

Muntean V, Mihailov A, Iancu C, Toganel R, Fabian O, Domsa I, et al. Staging laparoscopy in gastric cancer. Accuracy and im-pact on therapy. J Gastrointestin Liver Dis 2009; 18(2): 189‒95.

Conlon KC, Minnard EA. The Value of Laparoscopic Staging in Upper Gastrointestinal Malignancy. Oncologist 1997; 2(1): 10‒7.

Lehnert T, Rudek B, Kienle P, Buhl K, Herfarth C. Impact of di-agnostic laparoscopy on the management of gastric cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma. Br J Surg 2002; 89(4): 471‒5.

Jerby BL, Milsom JW. Role of laparoscopy in the staging of gas-trointestinal cancer. Oncology (Williston Park) 1998; 12(9): 1353‒60.

D’Ugo DM, Pende V, Persiani R, Rausei S, Picciocchi A. Laparo-scopic staging of gastric cancer: an overview. J Am Coll Surg 2003; 196(6): 965‒74.

Gross E, Bancewicz J, Ingram G. Assessment of gastric cancer by laparoscopy. Br Med J (Clin Res Ed) 1984; 288(6430): 1577.

Lowy AM, Mansfield PF, Leach SD, Ajani J. Laparoscopic stag-ing for gastric cancer. Surgery 1996; 119(6): 611‒4.

Stell DA, Carter CR, Stewart I, Anderson JR. Prospective com-parison of laparoscopy, ultrasonography and computed tomog-raphy in the staging of gastric cancer. Br J Surg 1996; 83(9): 1260‒2.

Kim DW, Park SA, Kim CG. Detecting the recurrence of gas-tric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT. J Korean Med Sci 2011; 26(7): 875–80.

Kaiser GM, Sotiropoulos GC, Fruhauf NR, Stavrou GA, Peitgen K, Pöttgen C, et al. Value of staging laparoscopy for multimodal therapy planning in esophago-gastric cancer. Int Surg 2007; 92(3): 128‒32.

Adamek HE, Maier M, Benz C, Huber T, Schilling D, Reimann JF. Severe complications in diagnostic laparoscopy. 9 years experience in 747 examinations. Med Klin (Munich) 1996; 91(11): 694‒7. (German)

Machairas N, Charalampoudis P, Molmenti EP, Kykalos S, Tsapa-ras P, Stamopoulos P, et al. The value of staging laparoscopy in gastric cancer. Ann Gastroenterol 2017; 30(3): 287‒94.

Karanicolas PJ, Elkin EB, Jacks LM, Atoria CL, Strong VE, Brennan MF, et al. Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg 2011; 213(5): 644‒51, 651.e1.

Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, et al. Staging and surgical approaches in gastric cancer: a clini-cal practice guideline. Curr Oncol 2017; 24(5): 324‒31.

Chang L, Stefanidis D, Richardson WS, Earle DB, Fanelli RD. The role of staging laparoscopy for intra abdominal cancers: an evidence-based review. Surg Endosc 2009; 23(2): 231–41.

Yamagata Y, Amikura K, Kawashima Y, Yatsuoka T, Nishimura Y, Sakamoto H, et al. Staging laparoscopy in advanced gastric cancer: usefulness and issues requiring improvement. Hepato-gastroenterology 2013; 60(124): 751–5.

Li K, Cannon JGD, Jiang SY, Sambare TD, Owens DK, Bendavid E, et al. Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis. J Surg Oncol 2018; 117(6): 1288‒96.

Frattini F, Rausei S, Chiappa C, Rovera F, Boni L, Dionigi G. Prognosis and treatment of patients with positive peritoneal cytology in advanced gastric cancer. World J Gastrointest Surg 2013; 5(5): 135‒7

Martin JK, Goellner JR. Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 1986; 61(6): 467‒71.

Iitsuka Y, Shiota S, Matsui T, Murata Y, Kimura A, Koga S. Rela-tionship between the cytologic characteristics of intraperito-neal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol 1990; 34(3): 437‒42.

Kaibara N, Iitsuka Y, Kimura A, Kobayashi Y, Hirooka Y, Nishi-doi H, et al. Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer 1987; 60(1): 136‒9.

Otsuji E, Kobayashi S, Okamoto K, Hagiwara A, Yamagishi H. Is timing of death from tumor recurrence predictable after cura-tive resection for gastric cancer? World J Surg 2001; 25(11): 1373‒6.

Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishi-kawa E, et al. Importance of positive peritoneal lavage cytolo-gy findings in the stage grouping of gastric cancer. Surg Today 1999; 29(2): 111‒5.

Kostić Z, Ćuk V, Bokun R, Ignjatović D, Ušaj-Knežević S, Ignjatović M. Detection of free cancer cells in peritoneal cavity in pa-tients surgically treated for gastric adenocarcinoma. Vojnosan-it Pregl 2006; 63(4): 349–56.

Akama F, Kajiwara K, Ishikawa H, Minami H, Nakamura Y. Cy-trogical examination of abdominal washings in gastric cancer surgery. In: Siewert JR, Roder JD, editors. Progress in gastric cancer surgery. Proceedings of the 2nd International Gastric Cancer Congress; 1997 Apr 27-30; Munich, Germany. Bolo-gna: Monduzzi; 1997. p. 321‒3.

Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy im-prove survival? Ann Surg Oncol 2008; 15(10): 2684‒91.

Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in pa-tients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005; 12(5): 347‒53.

Ly QP, Sasson AR. Modern surgical considerations for gastric cancer. J Natl Compr Canc Netw 2008; 6(9): 885‒94.

Nakajima T, Harashima S, Hirata M, Kajitani T. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Ac-ta Cytol 1978; 22(4): 225‒9.

Bando E, Yonemura Y, Takeshita Y, Yasui T, Yoshimitsu Y, Fu-shida S, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999; 178(3): 256‒62.

Tamura S, Fujiwara Y, Kimura Y, Fujita J, Imamura H, Kinuta M, et al. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: Results from a prospective multicenter clinical trial. J Surg Oncol 2014; 109(2): 75–80.

Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, et al. Human saliva, plasma and breast milk exosomes con-tain RNA: uptake by macrophages. J Transl Med 2011; 14: 9.

Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K, et al. Exosomal miRNAs from Peritoneum Lav-age Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer. PLoS One 2015; 10(7): e0130472.

Hamazoe R, Maeta M, Kaibara N. Intraperitoneal ther-mochemotherapy for prevention of peritoneal recurrence of gastric cancer: final results of a randomized controlled study. Cancer 1994; 73(8): 2048‒52.

Yonemura Y, De Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al. Intraoperative chemohyperthermic perito-neal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 2001; 48(42): 1776‒82.

Bryan RT, Cruickshank NR, Needham SJ, Moffitt DD, Young JA, Hallissey MT, et al. Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer. Eur J Surg Oncol 2001; 27(3): 291‒7.

Tustumi F, Bernardo WM, Dias AR, Ramos MF, Cecconello I, Zil-berstein B, et al. Detection value of free cancer cells in perito-neal washing in gastric cancer: a systematic review and meta-analysis. Clinics (Sao Paulo) 2016; 71(12): 733‒45.